Trials / Completed
CompletedNCT05173168
A Pilot Study to Assess the Safety Profile of resB®
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- ResBiotic Nutrition, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study investigates the safety and tolerability of 4-week, twice daily supplementation of resB® Lung Support in asthma patients and healthy participants.
Detailed description
resB® Lung Support is a probiotic dietary supplement that contains 3 probiotic strains and 3 herbal extracts: turmeric, holy basil, and vasaka. The proprietary herbal and probiotic blend is formulated to support proper lung structure and function. The study investigates the safety and tolerability of twice-daily supplementation of resB® Lung Support in asthma patients and healthy participants for 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic Dietary Supplement | Probiotic dietary supplement containing 3 probiotic strains and 3 herbal extracts |
Timeline
- Start date
- 2021-11-23
- Primary completion
- 2022-01-20
- Completion
- 2022-01-20
- First posted
- 2021-12-29
- Last updated
- 2022-04-29
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT05173168. Inclusion in this directory is not an endorsement.